DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "2013 France Tumor Marker Testing Market: Opportunities and Strategies for Suppliers" report to their offering.
This new 585-page analysis of the French tumor marker testing market report from Venture Planning Group including:
Major issues pertaining to the French laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Mortality statistics and scientific views on the etiology of major types of cancer, e.g., lung, colorectal, breast, prostatic, pancreatic, leukemia, lymphoma, gastrointestinal, bladder, liver, ovarian, testicular, oral, skin and others.
Ten-year test volume and sales forecasts for over 40 tumor markers performed in French hospitals and commercial laboratories.
Placements and installed base of automated and semi-automated analyzers used for tumor marker testing.
Current instrumentation technologies and feature comparison of leading analyzers.
Sales and market shares of leading suppliers.
Emerging diagnostic technologies and their potential market applications.
Product development opportunities.
Profiles of current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
Business opportunities and strategic recommendations for suppliers.
For more information visit Research and Markets
About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
